Phase 1 Study of Allo-RevCAR01-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies (1b Dose Expansion)

The Allo-RevCAR01-T-CD123 drug is a combination of a cellular component (Allo-RevCAR01-T) with a recombinant antibody derivative (R-TM123), which together form the active drug. The cellular component Allo-RevCAR01-T consists of an allogeneic human T-cell genetically multi-edited and expressing a reversed, universal chimeric antigen receptor (RevCAR) presenting an extracellular peptide epitope (RevCAR epitope). R-TM123 functions as a bridging module between Allo-RevCAR01-T and a CD123-expressing target cancer cell by selectively binding the RevCAR epitope and CD123.

Trial Details

NCT ID
NCT05949125
Phase
PHASE1
Sponsor
AvenCell Europe GmbH
Status
RECRUITING
Cancer Type
Acute Myeloid (AML) Leukemia
Interventions
  • Cyclophosphamide (Non-IMP, Lymphodepletion)
  • Fludarabine (Non-IMP, Lymphodepletion)
  • R-TM123
  • Allo-RevCAR01-T
Locations (sample)
  • Ulm, Baden-Wurttemberg, Germany|48.39841,9.99155
  • Munich, Bavaria, Germany|48.13743,11.57549
  • Würzburg, Bavaria, Germany|49.79391,9.95121
  • Marburg, Hesse, Germany|50.80904,8.77069
  • Dresden, Saxony, Germany|51.05089,13.73832

Key Eligibility Criteria

  • 1\. Male or female participants, age ≥18 years. 2. HLA type of participant must match at HLA B and C loci 3. Participants with CD123+ AML with morp…
  • Up to third relapse for whom all standard or life-extending therapies have failed and for whom no potentially curative therapies are available or w…
  • Without prior myeloproliferative neoplasm (MPN) or MDS/MPN (including leukemic transformation of MPN, "blast phase", and "accelerated phase" MPN), …
  • Exceptions to minimum CD123 expression are not allowed. 4. Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. 5. Life expectan…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Acute Myeloid (AML) Leukemia Trials on Trialify →